Integrin beta-8 (ITGB8) silencing reverses gefitinib resistance of human hepatic cancer HepG2/G cell line.

Wang, Wei-Wei; Wang, Yu-Bao; Wang, Dong-Qiang; Lin, Zhu; Sun, Ren-Jun

Wang, Wei-Wei; Wang, Yu-Bao; Wang, Dong-Qiang; Lin, Zhu; Sun, Ren-Jun.

Afiliação

Wang WW; Department of Emergency, Tianjin First Central Hospital Tianjin 300192 China.
Wang YB; Institute of Infectious Diseases, The Second Hospital of Tianjin Medical University Tianjin 300211 China.
Wang DQ; Department of Integration of Traditional Chinese and Western Medicine, Tianjin First Central Hospital Tianjin 300192 China.
Lin Z; Department of Intensive Care Unit, Tianjin First Central Hospital Tianjin 300192 China.
Sun RJ; Internal Medicine Department, Tianjin Occupational Disease Prevention Hospital Tianjin 300020 China.

Int J Clin Exp Med ; 8(2): 3063-71, 2015.

Article em En | MEDLINE | ID: mdl-25932283

Palavras-chave

Hepatic cancer; gefitinib resistance; integrin beta-8

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Revista: Int J Clin Exp Med Ano de publicação: 2015 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google